Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Nomination of Professor per Artursson as the recipient of the Björn Ekwall Memorial Award 2013

Nomination of Professor per Artursson as the recipient of the Björn Ekwall Memorial Award 2013 Nomination of Professor Per Artursson as the recipient of the Björn Ekwall Memorial Award 2013 Professor Per Artursson (M Sci Pharm, PhD) of the Department of Pharmaceutics at Uppsala Univer - sity, Sweden, was nominated for the 2013 Björn Ekwall Memorial Award, in recognition of his sci- entific achievements in the field of drug design and delivery, and for the innovative design and suc- cessful implementation of in vitro methods in pharmacology and pharmaceutical studies. Per Artursson has held a full professorship in Dosage Form Design at Uppsala University since 1992. His research has, since the late 1980s, focused on intestinal drug absorption and delivery. The aim is to understand drug absorption at the molecular and cellular level, in order to deliver drugs more effectively via the oral route. A further research focus is on the distribution and function of important drug-transporting proteins in the human body, in order to better understand drug disposition and drug interactions. During the course of this research, Professor Artursson has developed a number of new, scien- tifically-sound and animal-saving in vitro models based on advanced cell and molecular biology. These models have been adopted by the pharma- ceutical industry for the prediction of drug absorp- tion in the drug discovery process. In 2004, he founded a new unit in his depart- ment, dedicated to pharmaceutical screening and informatics — the Centre for Pharmaceutical Per Artursson Informatics (CPI), and in 2010, the unit was trans- West Sussex, UK (1987), before taking up a position formed into a National Platform for Drug Optim - as Assistant Professor in Pharmaceutics at Uppsala isation and Pharmaceutical Profiling (UDOPP). University. In 1992, he was appointed to his present This platform offers information and support, and post at the Department of Pharmacy, Uppsala promotes collaborative research between academia University. He is listed as one of the world’s 100 and industry, which is almost entirely based on in most cited scientists in Pharmacology and Tox - vitro and in silico methods. icology since 2004 (ISI). Professor Artursson studied pharmacy at Uppsala University, where he also was awarded his PhD in Professor Erik Walum, 1985. He spent one year as a post-doctoral fellow at on behalf of the BEMF board the Medical Products Agency, Uppsala (1986) and one year as a visiting scientist at the Advanced Drug Stockholm, 12 January 2013 Delivery Research Unit, Ciba-Geigy UK, Horsham, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

Nomination of Professor per Artursson as the recipient of the Björn Ekwall Memorial Award 2013

Walum, Erik
Alternatives to Laboratory Animals , Volume 41 (2): 1 – May 1, 2013
Download PDF
1 page

Loading next page...
 
/lp/sage/nomination-of-professor-per-artursson-as-the-recipient-of-the-bj-rn-VO9oea2H1q

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
SAGE
Copyright
© 2013 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119291304100216
Publisher site
See Article on Publisher Site

Abstract

Nomination of Professor Per Artursson as the recipient of the Björn Ekwall Memorial Award 2013 Professor Per Artursson (M Sci Pharm, PhD) of the Department of Pharmaceutics at Uppsala Univer - sity, Sweden, was nominated for the 2013 Björn Ekwall Memorial Award, in recognition of his sci- entific achievements in the field of drug design and delivery, and for the innovative design and suc- cessful implementation of in vitro methods in pharmacology and pharmaceutical studies. Per Artursson has held a full professorship in Dosage Form Design at Uppsala University since 1992. His research has, since the late 1980s, focused on intestinal drug absorption and delivery. The aim is to understand drug absorption at the molecular and cellular level, in order to deliver drugs more effectively via the oral route. A further research focus is on the distribution and function of important drug-transporting proteins in the human body, in order to better understand drug disposition and drug interactions. During the course of this research, Professor Artursson has developed a number of new, scien- tifically-sound and animal-saving in vitro models based on advanced cell and molecular biology. These models have been adopted by the pharma- ceutical industry for the prediction of drug absorp- tion in the drug discovery process. In 2004, he founded a new unit in his depart- ment, dedicated to pharmaceutical screening and informatics — the Centre for Pharmaceutical Per Artursson Informatics (CPI), and in 2010, the unit was trans- West Sussex, UK (1987), before taking up a position formed into a National Platform for Drug Optim - as Assistant Professor in Pharmaceutics at Uppsala isation and Pharmaceutical Profiling (UDOPP). University. In 1992, he was appointed to his present This platform offers information and support, and post at the Department of Pharmacy, Uppsala promotes collaborative research between academia University. He is listed as one of the world’s 100 and industry, which is almost entirely based on in most cited scientists in Pharmacology and Tox - vitro and in silico methods. icology since 2004 (ISI). Professor Artursson studied pharmacy at Uppsala University, where he also was awarded his PhD in Professor Erik Walum, 1985. He spent one year as a post-doctoral fellow at on behalf of the BEMF board the Medical Products Agency, Uppsala (1986) and one year as a visiting scientist at the Advanced Drug Stockholm, 12 January 2013 Delivery Research Unit, Ciba-Geigy UK, Horsham,

Journal

Alternatives to Laboratory Animals – SAGE

Published: May 1, 2013

There are no references for this article.